Search clinical trials for: Alogliptin and Pioglitazone

Total 272138 results

Takeda

Completed

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. (COMPLEMENT)

Diabetes Mellitus

United States, Puerto Rico
University Hospital, Geneva
University of Lausanne Hospitals

Completed

Renal and Hormonal Effects of Pioglitazone

Hypertension | Diabetes

Switzerland
Merck Sharp & Dohme LLC

Completed

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Coordinación de Investigación en Salud, Mexico

Completed

Pioglitazone and Metformin in Diabetic Children

Type 2 Diabetes

Mexico
Merck Sharp & Dohme LLC

Completed

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

Diabetes Mellitus, Type 2
AstraZeneca

Completed

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Diabetes Mellitus, Type 2

United States, Argentina, Canada, Puerto Rico, Mexico, Philippines, India, Peru
Takeda

Completed

An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus (TRACK)

Type 2 Diabetes Mellitus

Japan
Takeda

Terminated

Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2
University of Dhaka
University of Dundee; Bangladesh Institute of Research and Rehabilitation in...

Completed

Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects (T2DMCT)

Type 2 Diabetes Mellitus

Bangladesh
The University of Texas Health Science Center,...

Terminated

Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot)

Alcohol Use Disorder

United States
US Department of Veterans Affairs

Completed

Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance

Glucose Metabolism Disorders | Diabetes

United States
Versailles Hospital

Recruiting

Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) (ACTIW)

Leukemia, Myeloid, Chronic-Phase

France
Govind Ballabh Pant Hospital

Unknown

Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH) (NASH)

Metabolic Parameters and Liver Histology

India
The University of Texas Health Science Center,...
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Effects of Pioglitazone on Stress Reactivity and Alcohol Craving

Alcohol Use Disorder

United States
Emory University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Terminated

A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study) (APPEAL)

Alcoholism

United States
National Institute on Drug Abuse (NIDA)

Terminated

Pioglitazone to Treat Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Omeros Corporation

Terminated

Pioglitazone for Heroin and for Nicotine Dependence

Heroin Dependence | Nicotine Dependence

United States
Mayo Clinic

Terminated

Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function

Chronic Kidney Disease

United States
Takeda

Completed

Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

Type 2 Diabetes Mellitus

Japan
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)

Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd.

Unknown

A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Metabolic Disease | Renal Disease

Korea, Republic of
University of Leeds

Completed

Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes (Lean-DM)

Diabetes Mellitus, Type 2

United Kingdom
Metabolic Solutions Development Company

Completed

A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients

Diabetes Mellitus, Type 2

United States
Metabolic Solutions Development Company

Completed

A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator

Type 2 Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Type 2 Diabetes Mellitus

United States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
Takeda

Completed

Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
University of Prince Edward Island
OmniActive Health Technologies

Withdrawn

Capsaicinoid Ingestion, Human Metabolism and Exercise (Phase 2)

Exercise | Metabolism

Canada
AstraZeneca
Bristol-Myers Squibb

Completed

Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients

Type 2 Diabetes

Czech Republic, Korea, Republic of, Hungary, Poland, Ukraine, Philippines, Thailand
National Heart, Lung, and Blood Institute (NHLBI)
The Cleveland Clinic

Withdrawn

Hydroxyurea in Pulmonary Arterial Hypertension

Pulmonary Hypertension
Merck Sharp & Dohme LLC

Completed

A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

Type 2 Diabetes Mellitus
Universitaire Ziekenhuizen KU Leuven

Completed

Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls

Rhinitis

Belgium
Merck Sharp & Dohme LLC

Completed

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)

Diabetes Mellitus, Type 2
Takeda

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

Type 2 Diabetes Melitus
Takeda

Completed

Study of Combination Therapy With SYR-322

Diabetes Mellitus

Japan
Kyung Hee University Hospital at Gangdong
Dong-A ST Co., Ltd.

Unknown

A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin (EVOMETA)

Diabetes Mellitus, Type 2 | Bone Diseases, Metabolic

Korea, Republic of
The Catholic University of Korea
Jeil Pharmaceutical Co., Ltd.

Terminated

The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT) (PIONEER)

Coronary Artery Disease | Atherosclerosis

Korea, Republic of
UNICANCER

Completed

Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma

Brain and Central Nervous System Tumors

France
Wake Forest University Health Sciences
National Institute on Aging (NIA); Takeda Pharmaceuticals North America, Inc.

Completed

Optimizing Body Composition for Function in Older Adults

Obesity | Overweight With Indications for Weight Loss

United States
National Institute of Diabetes and Digestive and...

Completed

Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome (WU197)

HIV Infections | Cardiovascular Disease | Insulin Resistance | HIV Lipodystrophy | The Metabolic Syndrome

United States
University of Washington
National Heart, Lung, and Blood Institute (NHLBI); George Papanicolaou Hospital

Completed

Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major

Beta-Thalassemia

Greece
St. Jude Children's Research Hospital

Completed

Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS

Lymphoma

United States
National Institute on Alcohol Abuse and Alcoholism...

Terminated

Role of Proinflammatory Signaling in Alcohol Craving

Alcohol Drinking | Alcohol Dependence | Alcohol-Related Disorders | Stress

United States
Dr. Muhammad Abdulghani

Unknown

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Type 2 Diabetes

Qatar
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone

Diabetes Mellitus, Type 2

United States
AstraZeneca
Eli Lilly and Company

Completed

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

Type 2 Diabetes Mellitus

United States, Mexico, India
Takeda

Completed

Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Takeda

Terminated

Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus
Takeda

Completed

Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus (TRINITY)

Type 2 Diabetes Mellitus

Japan
Azienda Ospedaliero-Universitaria di Parma

Active, not recruiting

Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs (MIRACLE)

Newly Diagnosed Type 2 Diabetes

Italy
Merck Sharp & Dohme LLC

Completed

MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)

Type 2 Diabetes Mellitus

3

Subscribe